Serina Therapeutics, Inc. Finance Lease, Weighted Average Discount Rate, Percent
Serina Therapeutics, Inc. (SER) had Finance Lease, Weighted Average Discount Rate, Percent of 0.00% as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2026-03-25
- 2025-12-31: Finance Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2025-09-30: Finance Lease, Weighted Average Discount Rate, Percent 6.67%.
- 2025-06-30: Finance Lease, Weighted Average Discount Rate, Percent 6.67%.
- 2025-03-31: Finance Lease, Weighted Average Discount Rate, Percent 6.67%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent | Finance Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-25 | |
| 2025-09-30 | 6.67% 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 6.67% 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 6.67% 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 6.70% 10-K · filed 2026-03-25 | 6.67% 10-K · filed 2025-03-24 |
| 2024-09-30 | 6.67% 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 11.90% 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 11.90% 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 11.90% 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |